nursing and healthcare-associated pneumonia
Conditions
Interventions
None listed
Sponsors
Systematic review team of Japanese clinical practice guidelines of pneumonia, 2022
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with either nursing and healthcare-associated pneumonia defined by the 2017 JRS guidelines or healthcare-associated pneumonia defined by the 2005 ATS/IDSA guidelines.
Exclusion criteria
Exclusion criteria: pediatric patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The cure rate for pneumonia | — |
Secondary
| Measure | Time frame |
|---|---|
| Mortality assessed in each study, duration of hospital stay, the rate of readmission, failure rate of initial antibiotic therapy, the frequency and severity of adverse events, the occurrence of drug-resistant pathogens | — |
Countries
Japan
Contacts
Public ContactNatsuki Nakagawa
The University of Tokyo Department of pulmonary medicine
Outcome results
None listed